Skip to main content
SpringerLink
Log in

Many prescription drugs for outpatients are associated with QT risks

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Then MI, et al. The CredibleMeds(R) list: usage of QT interval prolonging drugs in Germany and discordances with prescribing information. British Journal of Clinical Pharmacology : 12 Jun 2021. Available from: URL: http://doi.org/10.1111/bcp.14951

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Many prescription drugs for outpatients are associated with QT risks. Reactions Weekly 1863, 9 (2021). https://doi.org/10.1007/s40278-021-98613-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-98613-1

Search

Navigation